Harvard Men's Health Watch

Drug no better than aspirin for stroke prevention

In the Journals A study published online May 10, 2016, by The New England Journal of Medicine found that the drug ticagrelor (Brilinta) could not beat aspirin for preventing stroke in certain high-risk patients. The study involved more than 13,000 people who had a mild stroke or a transient ischemic attack (TIA) within the previous 24 hours. A TIA is a brief episode of stroke-like symptoms, typically lasting less than 5 minutes and…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In